| Adverse events of sorafenib in hepatocellular carcinoma treatment Y Pang, A Eresen, Z Zhang, Q Hou, Y Wang, V Yaghmai, Z Zhang American Journal of Cancer Research 12 (6), 2770, 2022 | 22 | 2022 |
| Sorafenib plus memory like natural killer cell combination therapy in hepatocellular carcinoma A Eresen, Y Pang, Z Zhang, Q Hou, Z Chen, G Yu, Y Wang, V Yaghmai, ... American Journal of Cancer Research 14 (1), 344, 2024 | 4 | 2024 |
| Early assessment of irreversible electroporation ablation outcomes by analyzing MRI texture: preclinical study in an animal model of liver tumor A Eresen, K Zhou, C Sun, J Shangguan, B Wang, L Pan, S Hu, Y Pang, ... American journal of translational research 14 (8), 5541, 2022 | 4 | 2022 |
| MRI radiomics to monitor therapeutic outcome of sorafenib plus IHA transcatheter NK cell combination therapy in hepatocellular carcinoma G Yu, Z Zhang, A Eresen, Q Hou, EE Garcia, Z Yu, N Abi-Jaoudeh, ... Journal of Translational Medicine 22 (1), 76, 2024 | 3 | 2024 |
| Dendritic cell vaccination combined with irreversible electroporation for treating pancreatic cancer—a narrative review Z Zhang, G Yu, A Eresen, Z Chen, Z Yu, V Yaghmai, Z Zhang Annals of Translational Medicine, 2024 | 2 | 2024 |
| Differentiation of Irreversible Electroporation Regions in Normal and Tumor Tissues Using MRI Textures KLZZQHYPFNVYZZA Eresen Journal of Vascular and Interventional Radiology 34 (3), S25, 2023 | 1 | 2023 |
| Quantitative MRI Texture Analysis for Evaluating Treatment Response Following Irreversible Electroporation Ablation in Hepatocellular Carcinoma ZYZZJTVYZZA Eresen Journal of Vascular and Interventional Radiology 34 (3), S82, 2023 | 1* | 2023 |
| Sorafenib plus memory-like natural killer cell immunochemotherapy boosts treatment response in liver cancer A Eresen, Z Zhang, G Yu, Q Hou, Z Chen, Z Yu, V Yaghmai, Z Zhang BMC cancer 24 (1), 1215, 2024 | | 2024 |
| Abstract No. 204 Investigation of Natural Killer Cell Delivery in Hepatocellular Carcinoma Treatment with Magnetic Resonance Imaging Radiomics K Liu, G Yu, Z Zhang, Q Hou, V Yaghmai, A Eresen Journal of Vascular and Interventional Radiology 35 (3), S92, 2024 | | 2024 |
| Abstract No. 324 Evaluating Hepatocellular Carcinoma Combination Therapy of Sorafenib and Transcatheter Primed Natural Killer Cell Delivery Using MRI Radiomics Methods G Yu, A Eresen, Z Zhang, K Liu, Q Hou, V Yaghmai Journal of Vascular and Interventional Radiology 35 (3), S143-S144, 2024 | | 2024 |
| Abstract No. 342 Improving Therapeutic Response Against Hepatocellular Carcinoma with Cytokine-Activated Natural Killer Cells via Transcatheter Intraarterial Administration A Eresen, Z Zhang, G Yu, Q Hou, N Abi-Jaoudeh, V Yaghmai Journal of Vascular and Interventional Radiology 35 (3), S152, 2024 | | 2024 |
| Transcatheter Intraarterial Delivery of Combination Therapy for Hepatocellular Carcinoma ZZ Z. Zhang, A. Eresen, G. Yu, K. Liu, Q. Hou, V. Yaghmai Journal of Vascular and Interventional Radiology 35 (Issue 3), Page S199, 2024 | | 2024 |
| MRI monitoring of combined therapy with transcatheter arterial delivery of NK cells and systemic administration of sorafenib for the treatment of HCC Z Zhang, G Yu, A Eresen, Q Hou, V Yaghmai, Z Zhang American Journal of Cancer Research 14 (5), 2216, 2024 | | 2024 |
| Abstract No. 247 MRI Monitoring Transcatheter Intraportal Vein Delivery of Clinically Applicable-Magnetic Labeled Natural Killer Cells for Liver Tumor Adoptive immunotherapy A Eresen, Z Zhang, Z Yu, N Abi-Jaoudeh, F Nouizi, V Yaghmai Journal of Vascular and Interventional Radiology 34 (3), S112, 2023 | | 2023 |
| Abstract No. 241▪ FEATURED ABSTRACT MRI Monitoring Transcatheter Intraarterial Delivery of Clinical Magnetically Labeled Natural Killer Adoptive Immunotherapy Z Zhang, A Eresen, Z Chen, Z Yu, N Abi-Jaoudeh, V Yaghmai Journal of Vascular and Interventional Radiology 34 (3), S109, 2023 | | 2023 |
| Longitudinal Monitoring of Irreversible Electroporation Outcomes Using Hybrid Functional/Structural Variations of HCC Microenvironment FNAEZZVYGGZ Zhang Journal of Vascular and Interventional Radiology 34 (3), S7, 2023 | | 2023 |
